Results 251 to 260 of about 92,044 (339)

Implementation of a New Surgical Technique in a Gynecologic Oncology Centre: Sentinel Lymph Node Biopsy and Its Learning Curve in Endometrial Cancer. [PDF]

Cancers (Basel)
Koblížková M, Bretová P, Minář L, Felsinger M, Babjak B, Viktora L, Ovesná P, Hausnerová J, Jandáková E, Stupková T, Weinberger V.   +10 more
europepmc   +1 more source

Drive Time Analysis of New Gynecologic Oncology Patients at West Virginia University. [PDF]

J Appalach Health
Whitfield K, Cohen A, Pfaendler K, Ward K.   +3 more
europepmc   +1 more source

Are There Best Ways to Respond to a Patient With an AI‐Generated Answer You May Disagree With?

The Laryngoscope, EarlyView.
With the increasing use of generative artificial intelligence by patients, discrepancies in discussion can arise during the patient–physician clinic visit. This paper seeks to address practical guidelines for responding during a clinical encounter in which the physician disagrees with an AI‐generated medical answer brought forth by a patient.
Priyanka K. Bisarya, Katherine A. Hom, David B. Hom   +2 more
wiley   +1 more source

AI-driven radiogenomics in gynecologic oncology: from radiological digital biopsy to a new paradigm in precision therapy

Qiqi Kong, Yunqing Ban
openalex   +1 more source

Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study [PDF]

Eun Jung Yang, A Jin Lee, Woo Yeon Hwang, Suk‐Joon Chang, Hee Seung Kim, Nam Kyeong Kim, Yeorae Kim, Tae‐Wook Kong, Eun Ji Lee, Soo Jin Park, Joo‐Hyuk Son, Dong Hoon Suh, Dong Hee Son, Seung‐Hyuk Shim   +13 more
openalex   +1 more source

Mesna in Otologic Surgery: Efficacy and Safety—A Scoping Review

The Laryngoscope, EarlyView.
PRISMA flow diagram indicating the process of systematic inclusion and exclusion of articles. ABSTRACT Objective Mesna (Sodium 2‐mercaptoethanesulfonate) is widely used as a mucolytic agent and uroprotective agent. Recently, its disulfide bond‐breaking property has been applied in otologic surgery to facilitate safer dissection of cholesteatoma and ...
Kevork H. Atamian, Inabat Yermesheva, Ostap Orishchak, Hady Tall, Sam J. Daniel   +4 more
wiley   +1 more source

FIGO Cancer Report 2025: Transforming gynecologic oncology through global equity, technological innovation, and preventive strategies. [PDF]

Int J Gynaecol Obstet
Wilailak S, Berek JS.
europepmc   +1 more source

Enrichment of Hyaluronic Acid Binding Tumor Cells by Modulation of Selective Adhesion on Microgel Surfaces

Macromolecular Rapid Communications, EarlyView.
We have developed a thermoresponsive microgel system for the selective enrichment of hyaluronic acid‐binding tumor cells. By modulating the adhesion on the microgel surface via temperature changes from 37°C to 30°C, we demonstrate a novel proof‐of‐principle for separating these tumor cell from white blood cells, which has potential applications in ...
Melanie Schmidt, Dilay Karayel, André Franken, Janita Müller, Laura Hartmann, Klaus Pantel, Tanja Fehm, Hans Neubauer, Stephan Schmidt   +8 more
wiley   +1 more source

Japan Society of Gynecologic Oncology 2023 guidelines for treatment of uterine body neoplasm. [PDF]

J Gynecol Oncol
Morisada T, Kobayashi Y, Nagase S, Baba T, Tokunaga H, Watari H, Takekuma M, Terao Y, Terai Y, Kajiyama H, Asai-Sato M, Takehara K, Tabata T, Harano K, Hirashima Y, Yunokawa M, Okamoto A, Mikami M.   +17 more
europepmc   +1 more source

HMGB1 Assists in Overcoming Cisplatin Resistance in Chemoresistant Human Ovarian Cancer Cells

Molecular Carcinogenesis, EarlyView.
ABSTRACT Cisplatin is one of the most effective chemotherapeutic agents used in the treatment of ovarian cancer. However, the frequent development of cisplatin resistance remains a significant limitation, leading to therapeutic failure and poor patient outcomes.
Van Huynh, Guliang Wang, Anirban Mukherjee, Karen M. Vasquez   +3 more
wiley   +1 more source